BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 20830690)

  • 1. The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas.
    Stoll LM; Johnson MW; Gabrielson E; Askin F; Clark DP; Li QK
    Cancer Cytopathol; 2010 Dec; 118(6):441-9. PubMed ID: 20830690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TTF-1 and Napsin A double stain: a useful marker for diagnosing lung adenocarcinoma on fine-needle aspiration cell blocks.
    Fatima N; Cohen C; Lawson D; Siddiqui MT
    Cancer Cytopathol; 2011 Apr; 119(2):127-33. PubMed ID: 21287692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid transcription factor 1 and napsin a double staining in lung adenocarcinoma in pleural fluid.
    Liu L; Cohen C; Siddiqui MT
    Acta Cytol; 2012; 56(4):425-30. PubMed ID: 22846220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin.
    Hecht JL; Pinkus JL; Weinstein LJ; Pinkus GS
    Am J Clin Pathol; 2001 Oct; 116(4):483-8. PubMed ID: 11601132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
    Mukhopadhyay S; Katzenstein AL
    Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
    Bishop JA; Sharma R; Illei PB
    Hum Pathol; 2010 Jan; 41(1):20-5. PubMed ID: 19740516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions.
    Dejmek A; Naucler P; Smedjeback A; Kato H; Maeda M; Yashima K; Maeda J; Hirano T
    Diagn Cytopathol; 2007 Aug; 35(8):493-7. PubMed ID: 17636482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of napsin A and thyroid transcription factor 1 in differentiating metastatic pulmonary from non-pulmonary adenocarcinoma in pleural effusion.
    Kim JH; Kim YS; Choi YD; Lee JS; Park CS
    Acta Cytol; 2011; 55(3):266-70. PubMed ID: 21525739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma.
    Su YC; Hsu YC; Chai CY
    Kaohsiung J Med Sci; 2006 Jan; 22(1):14-9. PubMed ID: 16570563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.
    Kim MJ; Shin HC; Shin KC; Ro JY
    Ann Diagn Pathol; 2013 Feb; 17(1):85-90. PubMed ID: 23040737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms.
    Chang YL; Lee YC; Liao WY; Wu CT
    Lung Cancer; 2004 May; 44(2):149-57. PubMed ID: 15084379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas.
    Bejarano PA; Baughman RP; Biddinger PW; Miller MA; Fenoglio-Preiser C; al-Kafaji B; Di Lauro R; Whitsett JA
    Mod Pathol; 1996 Apr; 9(4):445-52. PubMed ID: 8729987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases.
    Sharma R; Wang Y; Chen L; Gurda GT; Geddes S; Gabrielson E; Askin F; Li QK
    Hum Pathol; 2016 Aug; 54():8-16. PubMed ID: 27045515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.
    Whithaus K; Fukuoka J; Prihoda TJ; Jagirdar J
    Arch Pathol Lab Med; 2012 Feb; 136(2):155-62. PubMed ID: 22288962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Napsin A is a useful marker for metastatic adenocarcinomas of pulmonary origin.
    Kim MY; Go H; Koh J; Lee K; Min HS; Kim MA; Jeon YK; Lee HS; Moon KC; Park SY; Kim WH; Chung DH
    Histopathology; 2014 Aug; 65(2):195-206. PubMed ID: 24479710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.
    El-Maqsoud NM; Tawfiek ER; Abdelmeged A; Rahman MF; Moustafa AA
    Tumour Biol; 2016 Mar; 37(3):3123-34. PubMed ID: 26427663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of 36 cases of pulmonary sarcomatoid carcinoma--sensitivity of TTF-1 is superior to napsin.
    Terra SB; Aubry MC; Yi ES; Boland JM
    Hum Pathol; 2014 Feb; 45(2):294-302. PubMed ID: 24331839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas.
    Siami K; McCluggage WG; Ordonez NG; Euscher ED; Malpica A; Sneige N; Silva EG; Deavers MT
    Am J Surg Pathol; 2007 Nov; 31(11):1759-63. PubMed ID: 18059234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
    Shi J; Liu H; Ma XJ; Chen Z; He MX; Luo Y; Lin F
    Arch Pathol Lab Med; 2016 Apr; 140(4):332-40. PubMed ID: 27028392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung.
    Ye J; Findeis-Hosey JJ; Yang Q; McMahon LA; Yao JL; Li F; Xu H
    Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):313-7. PubMed ID: 21464700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.